Log in

Diagnos News Headlines (CVE:ADK)

C$0.13
0.00 (0.00 %)
(As of 10/21/2019 01:27 AM ET)
Today's Range
C$0.12
Now: C$0.13
C$0.13
50-Day Range
C$0.11
MA: C$0.16
C$0.22
52-Week Range
C$0.11
Now: C$0.13
C$0.50
Volume9,500 shs
Average Volume66,211 shs
Market CapitalizationC$5.55 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Headlines

Diagnos (CVE ADK) News Headlines

Source:
DateHeadline
DIAGNOS Announces Closing of a Private PlacementDIAGNOS Announces Closing of a Private Placement
finance.yahoo.com - September 17 at 2:26 AM
DIAGNOS Receives Medical Device Marketing Authorization from the Saudi Food and Drug Authority to commercialize CARA in Saudi ArabiaDIAGNOS Receives Medical Device Marketing Authorization from the Saudi Food and Drug Authority to commercialize CARA in Saudi Arabia
www.nasdaq.com - September 10 at 10:27 PM
Should You Be Pleased About The CEO Pay At DIAGNOS Inc.s (CVE:ADK)Should You Be Pleased About The CEO Pay At DIAGNOS Inc.'s (CVE:ADK)
finance.yahoo.com - September 10 at 10:53 AM
Heres Why DIAGNOS (CVE:ADK) Might Be Better Off Without DebtHere's Why DIAGNOS (CVE:ADK) Might Be Better Off Without Debt
finance.yahoo.com - July 26 at 4:42 PM
DIAGNOS Announces an Extension to the Diabetic Retinopathy Screening Services Assisted by Artificial Intelligence (AI) at the CHUMDIAGNOS Announces an Extension to the Diabetic Retinopathy Screening Services Assisted by Artificial Intelligence (AI) at the CHUM
www.nasdaq.com - June 20 at 9:13 PM
DIAGNOS Announces Short Term FinancingDIAGNOS Announces Short Term Financing
www.globenewswire.com - June 17 at 4:11 PM
DIAGNOS Announces HIPAA Compliance for the US marketDIAGNOS Announces HIPAA Compliance for the US market
www.globenewswire.com - June 6 at 11:39 AM
Did You Manage To Avoid DIAGNOSs (CVE:ADK) Painful 68% Share Price Drop?Did You Manage To Avoid DIAGNOS's (CVE:ADK) Painful 68% Share Price Drop?
finance.yahoo.com - May 25 at 11:09 AM
DIAGNOS Announces Symbol Change on the OTCQB: DGNODDIAGNOS Announces Symbol Change on the OTCQB: DGNOD
www.globenewswire.com - May 8 at 4:15 PM
DIAGNOS Announces Saudi FDA Filing for its CARA AI PlatformDIAGNOS Announces Saudi FDA Filing for its CARA AI Platform
www.globenewswire.com - May 7 at 11:31 AM
DIAGNOS Joins Forces with a Cannabis-Based Medicinal Products DistributorDIAGNOS Joins Forces with a Cannabis-Based Medicinal Products Distributor
www.globenewswire.com - May 1 at 11:15 AM
DIAGNOS Redeems Convertible DebtDIAGNOS Redeems Convertible Debt
www.globenewswire.com - April 30 at 4:10 PM
DIAGNOS Successfully Completes ISO 13485:2016 MDSAP AuditDIAGNOS Successfully Completes ISO 13485:2016 MDSAP Audit
www.globenewswire.com - April 23 at 11:13 AM
DIAGNOS Will Supply Its Artificial Intelligence Technology to the First Hypertensive Retina Screening Clinic in Saudi Arabia.DIAGNOS Will Supply Its Artificial Intelligence Technology to the First Hypertensive Retina Screening Clinic in Saudi Arabia.
www.globenewswire.com - April 16 at 1:12 PM
DIAGNOS Announces Approval of Corporate ReorganizationDIAGNOS Announces Approval of Corporate Reorganization
www.globenewswire.com - April 10 at 4:16 PM
DIAGNOS Announces New Contract with Government in Bangladesh Through its Partner Eyes for AllDIAGNOS Announces New Contract with Government in Bangladesh Through its Partner Eyes for All
www.globenewswire.com - April 2 at 11:53 AM
DIAGNOS Announces an Update to the News Release Issued Earlier TodayDIAGNOS Announces an Update to the News Release Issued Earlier Today
www.globenewswire.com - March 27 at 4:19 PM
DIAGNOS Announces Memorandum of Understanding with one of the 5 largest hospitals in the US for the final development of its CARDIO applicationDIAGNOS Announces Memorandum of Understanding with one of the 5 largest hospitals in the US for the final development of its CARDIO application
www.globenewswire.com - March 27 at 12:27 PM
DIAGNOS Announces New Agreement in the United Arab Emirates with one of the Largest Pharmaceutical Companies in the WorldDIAGNOS Announces New Agreement in the United Arab Emirates with one of the Largest Pharmaceutical Companies in the World
www.globenewswire.com - March 13 at 4:10 PM
DIAGNOS Welcomes Dr. Jean-Francois Yale to the Board of DirectorsDIAGNOS Welcomes Dr. Jean-Francois Yale to the Board of Directors
globenewswire.com - January 29 at 11:19 AM
DIAGNOS is announcing a collaboration with ÉTS on Automated detection and grading of Diabetic Retinopathy ...DIAGNOS is announcing a collaboration with ÉTS on Automated detection and grading of Diabetic Retinopathy ...
globenewswire.com - December 4 at 11:08 AM
DIAGNOS Announces Today the Addition of a Strategic Partner in the Country of MexicoDIAGNOS Announces Today the Addition of a Strategic Partner in the Country of Mexico
www.marketwatch.com - November 13 at 3:34 PM
DIAGNOS to Provide Retinal Image Analysis using its AI Technology to 20/20NOW, the Leading Ocular Telehealth Provider in the United StatesDIAGNOS to Provide Retinal Image Analysis using its AI Technology to 20/20NOW, the Leading Ocular Telehealth Provider in the United States
globenewswire.com - September 20 at 11:11 AM
Optina Diagnostics and Diagnos Partner for Online Alzheimers Disease Detection PlatformOptina Diagnostics and Diagnos Partner for Online Alzheimer's Disease Detection Platform
www.baystreet.ca - September 5 at 3:27 PM
DIAGNOS Partners with Optina Diagnostics, a Montreal Based Company, to Provide a Web Platform for the Early Detection of Alzheimer DiseaseDIAGNOS Partners with Optina Diagnostics, a Montreal Based Company, to Provide a Web Platform for the Early Detection of Alzheimer Disease
globenewswire.com - September 5 at 10:46 AM
DIAGNOS Installs its First Retina Screening Clinic based on Artificial Intelligence in PanamaDIAGNOS Installs its First Retina Screening Clinic based on Artificial Intelligence in Panama
globenewswire.com - July 10 at 9:54 AM
DIAGNOS Broadens its Collaboration with the Government of MexicoDIAGNOS Broadens its Collaboration with the Government of Mexico
globenewswire.com - July 4 at 10:11 AM
Cancer Diagnostics: A Market on the Verge of Explosion--Supplier Shares and Market Segment Forecasts by Tests--Technological Breakthroughs, Emerging Tests, Competitive IntelligenceCancer Diagnostics: A Market on the Verge of Explosion--Supplier Shares and Market Segment Forecasts by Tests--Technological Breakthroughs, Emerging Tests, Competitive Intelligence
www.prnewswire.com - June 27 at 1:19 PM
Great Heights Opens in Fort Wayne to Provide ABA Treatment for Children Diagnosed with AutismGreat Heights Opens in Fort Wayne to Provide ABA Treatment for Children Diagnosed with Autism
www.prnewswire.com - June 26 at 10:37 AM
MIM Software Inc. schließt sich mit Spectrum Dynamics Medical zusammenMIM Software Inc. schließt sich mit Spectrum Dynamics Medical zusammen
www.prnewswire.com - June 24 at 10:15 AM
One Third of Participants in a Workforce Study Reduce Risk for Diabetes after Employer Wellness Screening and Behavioral Counseling, Finds Quest Diagnostics StudyOne Third of Participants in a Workforce Study Reduce Risk for Diabetes after Employer Wellness Screening and Behavioral Counseling, Finds Quest Diagnostics Study
www.prnewswire.com - June 23 at 11:52 AM
DNA Diagnostics Center® Ready to Provide Expedited Legally-Binding Immigration DNA Testing for Border FamiliesDNA Diagnostics Center® Ready to Provide Expedited Legally-Binding Immigration DNA Testing for Border Families
www.prnewswire.com - June 22 at 1:54 PM
Hepatitis Diagnostic Market Size Worth USD 6.9 Billion by 2025: Grand View Research, Inc.Hepatitis Diagnostic Market Size Worth USD 6.9 Billion by 2025: Grand View Research, Inc.
www.prnewswire.com - June 18 at 6:01 AM
EMOSIS meldet Alleinvertriebsvereinbarung mit 5-Diagnostics und KommerzialisierungsbeginnEMOSIS meldet Alleinvertriebsvereinbarung mit 5-Diagnostics und Kommerzialisierungsbeginn
www.prnewswire.com - June 18 at 6:01 AM
EMOSIS Announces an Exclusive Distribution Agreement with 5-Diagnostics and the Start of CommercializationEMOSIS Announces an Exclusive Distribution Agreement with 5-Diagnostics and the Start of Commercialization
www.prnewswire.com - June 14 at 4:30 AM
DIAGNOS Announces the Availability of its New CARA High Blood Pressure Risk Assessment Based on its FLAIRE Artificial Intelligence PlatformDIAGNOS Announces the Availability of its New CARA High Blood Pressure Risk Assessment Based on its FLAIRE Artificial Intelligence Platform
globenewswire.com - June 13 at 9:30 AM
Fluke DS701 and DS703 FC Diagnostic Videoscopes enable maintenance teams to diagnose problems without tearing down equipmentFluke DS701 and DS703 FC Diagnostic Videoscopes enable maintenance teams to diagnose problems without tearing down equipment
www.prnewswire.com - June 13 at 6:25 AM
Global Molecular Diagnostics IndustryGlobal Molecular Diagnostics Industry
www.prnewswire.com - June 11 at 3:43 PM
Quest Diagnostics Unveils Quanum™ Enterprise Content Solutions, Formerly Named ChartMaxx®Quest Diagnostics Unveils Quanum™ Enterprise Content Solutions, Formerly Named ChartMaxx®
www.prnewswire.com - June 11 at 9:19 AM
Western European Cardiac Troponin Diagnostics Market to 2021Western European Cardiac Troponin Diagnostics Market to 2021
www.prnewswire.com - June 6 at 6:13 PM
Exact Sciences, Mayo Clinic Researchers Identify Blood-Based DNA Biomarker Panel to Accurately Diagnose Hepatocellular CarcinomaExact Sciences, Mayo Clinic Researchers Identify Blood-Based DNA Biomarker Panel to Accurately Diagnose Hepatocellular Carcinoma
www.prnewswire.com - June 5 at 4:34 PM
Accelerate Diagnostics to Present at the William Blair 38th Annual Growth Stock ConferenceAccelerate Diagnostics to Present at the William Blair 38th Annual Growth Stock Conference
feeds.benzinga.com - June 5 at 12:12 PM
Quest Diagnostics To Speak At The William Blair 38th Annual Growth Stock ConferenceQuest Diagnostics To Speak At The William Blair 38th Annual Growth Stock Conference
www.prnewswire.com - June 4 at 4:49 PM
Results of Kamadas Phase 2 Trial of Alpha-1 Antitrypsin in Newly Diagnosed Type-1 Diabetes Patients to be Presented at the Upcoming American Diabetes Associations 78th Scientific SessionsResults of Kamada's Phase 2 Trial of Alpha-1 Antitrypsin in Newly Diagnosed Type-1 Diabetes Patients to be Presented at the Upcoming American Diabetes Association's 78th Scientific Sessions
feeds.benzinga.com - June 4 at 7:58 AM
COPAN Announces Lawsuit for Patent Infringement and Unfair Competition Against Puritan Medical Products Co., LLC and Puritan Diagnostics LLCCOPAN Announces Lawsuit for Patent Infringement and Unfair Competition Against Puritan Medical Products Co., LLC and Puritan Diagnostics LLC
www.prnewswire.com - June 4 at 6:09 AM
Global Molecular Diagnostics Market 2018-2023 with Roche, Hologic, QIAGEN, Abbott and Danaher Dominating the $11.5 Billion MarketGlobal Molecular Diagnostics Market 2018-2023 with Roche, Hologic, QIAGEN, Abbott and Danaher Dominating the $11.5 Billion Market
www.prnewswire.com - May 31 at 7:16 PM
Express Scripts to Provide Patients with Faster Path to Rare Disease Diagnosis and Treatment, in Collaboration with PinnacleCareExpress Scripts to Provide Patients with Faster Path to Rare Disease Diagnosis and Treatment, in Collaboration with PinnacleCare
www.prnewswire.com - May 31 at 8:16 AM
FleetPride Offers Interest-Free Financing On Jaltest All-Makes Diagnostic ToolsFleetPride Offers Interest-Free Financing On Jaltest All-Makes Diagnostic Tools
www.prnewswire.com - May 29 at 5:43 PM
Co-Diagnostics up 65%Co-Diagnostics up 65%
seekingalpha.com - May 29 at 12:34 PM
Why It Is Harder to Diagnose Hospital StocksWhy It Is Harder to Diagnose Hospital Stocks
www.wsj.com - May 28 at 6:33 AM
This page was last updated on 10/21/2019 by MarketBeat.com Staff

Featured Article: Float

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel